The stock's fall snapped a five-day winning streak.

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

A rough earnings report raised troubling questions about UHG’s future, and so did the resignation of CEO Andrew Witty.

Cigna confidently reaffirmed its 2025 financial outlook, aiming for a minimum of $29.60 per share in adjusted operational ...